BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 23277306)

  • 1. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease.
    Ducrocq G; Amarenco P; Labreuche J; Alberts MJ; Mas JL; Ohman EM; Goto S; Lavallée P; Bhatt DL; Steg PG
    Circulation; 2013 Feb; 127(6):730-8. PubMed ID: 23277306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
    Smith EE; Cannon CP; Murphy S; Feske SK; Schwamm LH
    Am Heart J; 2006 Feb; 151(2):338-44. PubMed ID: 16442896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack.
    James SK; Storey RF; Khurmi NS; Husted S; Keltai M; Mahaffey KW; Maya J; Morais J; Lopes RD; Nicolau JC; Pais P; Raev D; Lopez-Sendon JL; Stevens SR; Becker RC;
    Circulation; 2012 Jun; 125(23):2914-21. PubMed ID: 22572911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of stroke/transient ischemic attack among patients with acute coronary syndromes in a real-world setting.
    Deitelzweig SB; Ogbonnaya A; Berenson K; Lamerato LE; Costas JP; Makenbaeva D; Corbelli J
    Hosp Pract (1995); 2010 Nov; 38(4):7-17. PubMed ID: 21068522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA; Chalakova NT; Dimitrov BD
    Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein predicts further ischemic events in transient ischemic attack patients.
    Purroy F; Montaner J; Molina CA; Delgado P; Arenillas JF; Chacon P; Quintana M; Alvarez-Sabin J
    Acta Neurol Scand; 2007 Jan; 115(1):60-6. PubMed ID: 17156267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
    Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
    Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice.
    Heeley E; Anderson C; Patel A; Cass A; Peiris D; Weekes A; Chalmers J
    Int J Stroke; 2012 Dec; 7(8):649-54. PubMed ID: 21978147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient atrial fibrillation and risk of stroke after acute myocardial infarction.
    Bishara R; Telman G; Bahouth F; Lessick J; Aronson D
    Thromb Haemost; 2011 Nov; 106(5):877-84. PubMed ID: 21866303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral microbleeds are common in ischemic stroke but rare in TIA.
    Werring DJ; Coward LJ; Losseff NA; Jäger HR; Brown MM
    Neurology; 2005 Dec; 65(12):1914-8. PubMed ID: 16380612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
    De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
    J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.
    Kohli P; Wallentin L; Reyes E; Horrow J; Husted S; Angiolillo DJ; Ardissino D; Maurer G; Morais J; Nicolau JC; Oto A; Storey RF; James SK; Cannon CP
    Circulation; 2013 Feb; 127(6):673-80. PubMed ID: 23277305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Death and rehospitalization after transient ischemic attack or acute ischemic stroke: one-year outcomes from the adherence evaluation of acute ischemic stroke-longitudinal registry.
    Olson DM; Cox M; Pan W; Sacco RL; Fonarow GC; Zorowitz R; Labresh KA; Schwamm LH; Williams L; Goldstein LB; Bushnell CD; Peterson ED;
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e181-8. PubMed ID: 23273788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial.
    Mehra MR; Vaduganathan M; Fu M; Ferreira JP; Anker SD; Cleland JGF; Lam CSP; van Veldhuisen DJ; Byra WM; Spiro TE; Deng H; Zannad F; Greenberg B
    Eur Heart J; 2019 Nov; 40(44):3593-3602. PubMed ID: 31461239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early risk and predictors of cerebrovascular and cardiovascular events in transient ischemic attack and minor ischemic stroke.
    Kate M; Sylaja PN; Chandrasekharan K; Balakrishnan R; Sarma S; Pandian JD
    Neurol India; 2012; 60(2):165-7. PubMed ID: 22626697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2.
    Tada T; Natsuaki M; Morimoto T; Furukawa Y; Nakagawa Y; Byrne RA; Kastrati A; Kadota K; Iwabuchi M; Shizuta S; Tazaki J; Shiomi H; Abe M; Ehara N; Mizoguchi T; Mitsuoka H; Inada T; Araki M; Kaburagi S; Taniguchi R; Eizawa H; Nakano A; Suwa S; Takizawa A; Nohara R; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Circ Cardiovasc Interv; 2012 Jun; 5(3):381-91. PubMed ID: 22619260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke.
    Rothwell PM; Howard SC; Power DA; Gutnikov SA; Algra A; van Gijn J; Clark TG; Murphy MF; Warlow CP
    Stroke; 2004 Oct; 35(10):2300-5. PubMed ID: 15345800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
    Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
    Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology, risk factors and sex differences in ischemic stroke in the Ludwigshafen Stroke Study, a population-based stroke registry.
    Palm F; Urbanek C; Wolf J; Buggle F; Kleemann T; Hennerici MG; Inselmann G; Hagar M; Safer A; Becher H; Grau AJ
    Cerebrovasc Dis; 2012; 33(1):69-75. PubMed ID: 22133999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.